VALIANTLAB logo

Valiant Laboratories LTD

VALIANTLAB·NSE·
95.00 +3.44 (+3.76%)
Market Cap522.11 Cr
PE Ratio63.54
Volume40,793
Day High - Low96.00 - 92.58
52W High-Low110.70 - 49.51
DocStoX Score
2.5/10
Poor
Fair Value
Sign in to see
ROE
-1.20%
Weak
P/E
63.54x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day92.58
96.00
52W49.51
110.70
DocStoX take

Supported by momentum (7.5), but held back by quality (0.8). Momentum looks strong at 7.5, but that is offset by quality at 0.8 and growth at 1.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.5
/10
Poor
Quality
Weak
ROE -1.2%
Valuation
Rich
P/E 63.5×
Growth
Flat
Revenue +5.4% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
74% of 52-week range

At a glance

Market Cap
₹522 Cr
52W High / Low
₹111 / ₹50
Dividend Yield
0.00%
Promoter Holding
74.94%
EPS (TTM)
₹1.50
Book Value
₹57.20

Key highlights

  • Low leverage — D/E 0.00
  • Profit shrinking 41% a year
  • Loss-making in some of the last 5 years
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

VALIANT LABORATORIES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.